Clinical Trials Directory

Trials / Unknown

UnknownNCT04779359

Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease

The Predictive Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease- A Retrospective Study

Status
Unknown
Phase
Study type
Observational
Enrollment
1 (estimated)
Sponsor
Shanghai Public Health Clinical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To investigate the predictive role of lymphocyte subsets and other laboratory measurements in adult patients with COVID-19.This was a single center, retrospective study that involved adult patients with confirmed diagnosis of COVID-19. Electronic medical records were reviewed. Data including age, sex, symptom from onset to hospital admission and laboratory findings at admission of hospitalized patients with confirmed COVID-19 were extracted and analyzed retrospectively.This study indicates that the levels of lymphocyte subsets (CD4+, and CD8+) are associated with disease progression and severity, along with prognosis in patients with COVID-19.

Detailed description

This was a single center, retrospective study that involved adult patients with confirmed diagnosis of COVID-19. Electronic medical records were reviewed. Data including age, sex, symptom from onset to hospital admission and laboratory findings at admission of hospitalized patients with confirmed COVID-19 were extracted and analyzed retrospectively. Identifying the possible immune factors and laboratory parameters is requisite for the early identification of patients with severe COVID-19 and timely intervention for control of the disease. There is an unmet need to establish robust clinical cutoffs of lymphocyte subsets for predicting risk associated with ICU admission, mechanical ventilation, and mortality in COVID-19 patients. This retrospective study was thus carried out to improve knowledge and clinical utility of lymphocyte subset measurements, together with other laboratory measurements and clinical information, for understanding prognosis in COVID-19 patients. These findings suggest that alterations in lymphocyte subsets and laboratory measurements play a significant role in the progression of COVID-19.

Conditions

Timeline

Start date
2021-04-01
Primary completion
2021-08-01
Completion
2021-12-01
First posted
2021-03-03
Last updated
2021-03-03

Source: ClinicalTrials.gov record NCT04779359. Inclusion in this directory is not an endorsement.